CEO Jan Schrooten moderates 'The Power of Cell & Gene' session on Knowledge for Growth
All expertise from previous editions is combined into the very first hybrid Knowledge for Growth conference in Ghent. On 27, 28 and 29 September, you can join interactive workshops, company pitches, live panel debates and top-level keynotes. Both on-site (September 28) and online (September 27-29).
Have a look at the agenda and discover all themes of the on-site programme: Academic, Agro-FoodTech, Business & Finance, Data, On-demand, Personalized Medicine, Pitch Session, Preventive Medicine and Research to Business.
On September 28, Jan Schrooten will moderate 'the power of cell & gene' session in the 'Personalized Medicine' track:
Session 'The Power of Cell & Gene'
Moderated by Jan Schrooten, CEO & Co-Founder - Antleron
Date: September 28
Stage: Van Eyck
· Michael Linden, CSO & Co-Founder - Handl Therapeutics
· Pieter Rottiers, CEO - Precigen ActoBio
· Steven Powell, CEO - eTheRNA
· Erwin Blomsma, CEO & Co-Founder - Virovet
The use of a personalized therapies offers new opportunities in treating lethal or debilitating diseases. Generated based on patients’ own cells, or using vectors to correct faulty genes, these medicines could be the answer where conventional treatments failed. With the current understanding of genetics, improved diagnostics, and progressing cell and gene therapies, a future with fully personalized medicine is closer than ever. The speakers around the table - all pioneers and innovators in their own way - will dig deeper into opportunities and challenges related to the power of cell and gene.